Hunan Hansen Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Hunan Hansen Pharmaceutical has a total shareholder equity of CN¥2.1B and total debt of CN¥79.8M, which brings its debt-to-equity ratio to 3.8%. Its total assets and total liabilities are CN¥2.5B and CN¥351.4M respectively. Hunan Hansen Pharmaceutical's EBIT is CN¥247.1M making its interest coverage ratio -11.3. It has cash and short-term investments of CN¥370.8M.
Key information
3.8%
Debt to equity ratio
CN¥79.80m
Debt
| Interest coverage ratio | -11.3x |
| Cash | CN¥370.82m |
| Equity | CN¥2.10b |
| Total liabilities | CN¥351.41m |
| Total assets | CN¥2.45b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002412's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥325.5M).
Long Term Liabilities: 002412's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥26.0M).
Debt to Equity History and Analysis
Debt Level: 002412 has more cash than its total debt.
Reducing Debt: 002412's debt to equity ratio has reduced from 15% to 3.8% over the past 5 years.
Debt Coverage: 002412's debt is well covered by operating cash flow (162.1%).
Interest Coverage: 002412 earns more interest than it pays, so coverage of interest payments is not a concern.